Current Research Studies

Allogeneic hematopoietic cell transplantation for patients with non-malignant disorders using Treosulfan, Fludarabine, and Thiotepa

FH9621 TREO TT

Condition(s): BMT
Phase: II
Clinicaltrials.gov ID: NCT03980769

What is the goal of the study?

Allogeneic hematopoietic cell transplantation for patients with non-malignant disorders using Treosulfan, Fludarabine, and Thiotepa

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Lauri Burroughs
Study Team Member: Courtney Vandervlugt, [email protected]